CROI: Impact of Semaglutide on Weight Change Among People with HIV: A Stratified Analysis by Baseline BMI - (03/11/24) CROI: Effects of Semaglutide on Muscle Structure and Function in the SLIM Liver Study - (03/12/24) CROI: Semaglutide Lowers Some Inflammation Markers in HIV Lipohypertrophy - (03/12/24) CROI: Effects of Semaglutide on Inflammation and Immune Activation in HIV-Associated Lipohypertrophy....people with severe lipoatrophy were excluded from study, so were diabetics & CVD - (03/11/24) CROI: Effects of Semaglutide on Muscle Structure and Function in the SLIM Liver Study - (03/12/24) CROI: Semaglutide Lowers Some Inflammation Markers in HIV Lipohypertrophy - (03/12/24) CROI: Low-Dose Semaglutide Cuts Weight, Triglycerides, and Glucose in HIV MASLD Group - (03/12/24) CROI: Race/Ethnicity and Risk of NAFLD and Clinically Significant Fibrosis in Persons Living with HIV - (03/12/24) CROI: NAFLD and Advanced Fibrosis Are Common in Adults With HIV and Associated With Unique Histology - (03/12/24) CROI: Weight Loss 5.7% at 1 Year With Semaglutide in HIV - Mark Mascolini (03/11/24) 100 NATAP CROI Reports Conference on Retroviruses and Opportunistic Infections Virtual Mar 3 -, Mar 6, 2024

Does Yerba Mate have Glucagon-like peptide-1 (GLP-1) effects?
The Centers for Disease Control and Prevention (CDC) recommends ciprofloxacin as the antibiotic for initial prophylactic therapy among asymptomatic pregnant women exposed to Bacillus anthracis 2
The trial, formally titled ManagEment of OverWeight cats with OKV-119 (MEOW-1), is the first-ever GLP-1 weight loss trial in domestic pets
These data indicate that NO-associated redox reactions occurring in the mitochondria play an important role in ASD, although the exact mechanisms implicating NO in this role need further investigation
Source: Jimena Tatiana Hathaway, MD, MPH